Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment-Reference-Cited by-同舟云学术

Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment

Published:2017-04-17 Issue:34 Volume:36 Page:4875-4886
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Nandhu M S,Kwiatkowska A,Bhaskaran V,Hayes J,Hu B,Viapiano M S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/onc2017109.pdf

Reference66 articles.

1. Zong H, Verhaak RG, Canoll P . The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn 2012; 12: 383–394.

2. Watkins S, Sontheimer H . Unique biology of gliomas: challenges and opportunities. Trends Neurosci 2012; 35: 546–556.

3. Wen PY, Kesari S . Malignant gliomas in adults. N Engl J Med 2008; 359: 492–507.

4. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 2014; 16 (Suppl 4): iv1–63.

5. Chen J, McKay RM, Parada LF . Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 2012; 149: 36–47.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radionuclide Therapy in Brain Tumours;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

2. Investigational Microbiological Therapy for Glioma;Cancers;2022-12-02

3. EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt/β-catenin and TGF-β/Smad2/3 signal pathways;Journal of Bone Oncology;2022-12

4. α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth;JCI Insight;2022-11-08

5. The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling;Frontiers in Oncology;2022-10-11